Abridge is trying to turn AI medical notes into something much bigger. The health AI startup has launched a clinician intelligence platform that supports care teams before, during, and after patient encounters, while also partnering with Nvidia to build a foundation model designed specifically for clinical conversations.
The model will be built on Nvidia’s Nemotron open model family and trained on Nvidia Blackwell AI infrastructure using de-identified clinical data. Rather than adapting a general-purpose model after the fact, Abridge and Nvidia are working to embed clinical knowledge earlier in the model development process. Kimberly Powell, Nvidia’s Vice President of Healthcare, said there is an opportunity to adapt models with clinical intelligence “at a much earlier stage of model development.”
Abridge’s new platform is designed to prepare clinicians with pre-charted notes, capture conversations during care, generate documentation afterward, and support clinical decision-making through medical evidence and institutional guidelines.
The platform is already live at more than 300 health systems and supports more than 100 million conversations annually. Abridge also announced that Northwestern Medicine is implementing the platform enterprise-wide across all hospitals and care settings.
The company is expanding beyond physicians into nursing, payment workflows, and clinical research. Its nursing tools can turn bedside conversations into structured electronic health record documentation, while its payer-focused tools are designed to connect clinical documentation with coding and claims workflows. Abridge said it is working with organizations including Aetna, Cigna, and health information professionals on payment alignment.
Abridge is also adding clinical decision support through medical sources such as Wolters Kluwer’s UpToDate, the American Diabetes Association, the American Academy of Family Physicians, and other evidence-based content partners. In life sciences, the platform can compare patient records and clinical conversations against trial criteria to help identify potential research candidates at the point of care.
Abridge CEO and Co-Founder Dr. Shiv Rao said the company’s goal is to bring trusted intelligence into “the most important moment in medicine: a clinician caring for a patient.”
